Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ADAP - Adaptimmune Therapeutics plc
-59 M
LAST VALUE
-28.89%
2 YEAR CAGR
-10.14%
5 YEAR CAGR
-44.85%
10 YEAR CAGR